Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
24
Number of overlapping holdings
38.7%
% of XLV's 62 holdings also in PINK
45.3%
% of PINK's 56 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus PINK)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in PINK |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.0% | 6.5% | 6.5% |
|
UNITEDHEALTH GROUP INC | 9.3% | 5.4% | 5.4% |
|
MERCK & CO. INC. | 5.0% | 4.5% | 4.5% |
|
INTUITIVE SURGICAL INC | 3.7% | 4.8% | 3.7% |
|
THERMO FISHER SCIENTIFIC INC | 3.9% | 3.5% | 3.5% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to PINK
|
ABBVIE INC | 5.9% |
|
ELI LILLY & CO | 5.6% |
|
JOHNSON & JOHNSON | 4.2% |
|
UNITEDHEALTH GROUP INC | 3.9% |
|
ABBOTT LABORATORIES | 3.2% |
|
AMGEN INC | 2.8% |
|
PFIZER INC | 2.8% |
|
DANAHER CORP | 2.7% |
|
VERTEX PHARMACEUTICALS INC | 2.3% |
|
STRYKER CORP | 2.2% |
XLV Underweight Relative to PINK
|
SAREPTA THERAPEUTICS INC | -10.6% |
|
PURECYCLE TECHNOLOGIES INC | -5.8% |
 |
SANOFI-AVENTIS-ADR | -5.0% |
 |
NOVO-NORDISK A/S-SPONS ADR | -3.5% |
|
REGENERON PHARMACEUTICALS | -3.3% |
|
3M CO | -3.1% |
|
NEUROCRINE BIOSCIENCES INC | -2.3% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -2.1% |
|
PERKINELMER INC | -1.8% |
|
BOSTON SCIENTIFIC CORP | -1.6% |